Frontotemporal dementia patients with extrapyramidal symptoms have brainstem atrophy and reduced metabolism in certain areas of the brain significantly more often than patients without extrapyramidal ...
Credit: Getty Images. Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare ...
EPSs are serious, debilitating and stigmatizing adverse effects that frequently require additional pharmacotherapy. 3 The two types of EPSs are as follows: early acute EPS, which most often develops ...
One of the challenging features of neurodegenerative diseases is that they tend to defy the clinician’s desire for neat categorization, as many patients suffer a range of symptoms across intersecting ...
AS the so-called "tranquilizing drugs" continue to increase in use and misuse, the physician will become more aware of the alarming side reactions that may be inherent in their pharmacologic formulas.
The approval of Osmolex ER was based on bioavailability studies comparing Osmolex ER to immediate-release amantadine. Osmotica announced that the Food and Drug Administration (FDA) has approved ...
The diagnosis of VV1 sporadic Creutzfeldt–Jakob disease (sCJD) is extremely difficult, as this very rare subtype of sCJD shares many clinical characteristics with variant CJD (vCJD). Between 1993 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback